Results 201 to 210 of about 6,871,211 (381)

Feature selection using tabu search method [PDF]

open access: green, 2002
Hongbin Zhang, Guangyu Sun
openalex   +1 more source

Feature selection in machine learning: A new perspective

open access: yesNeurocomputing, 2018
Jie Cai   +3 more
semanticscholar   +1 more source

Time, the final frontier

open access: yesMolecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain   +3 more
wiley   +1 more source

Causality, Machine Learning, and Feature Selection: A Survey. [PDF]

open access: yesSensors (Basel)
Lamsaf A   +3 more
europepmc   +1 more source

On Feature Selection with Measurement Cost and Grouped Features [PDF]

open access: bronze, 2002
Pavel Paclı́k   +3 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Feature Selection for Clustering [PDF]

open access: yes, 2009
Manoranjan Dash, Poon Wei Koot
openaire   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy